Provided by Tiger Trade Technology Pte. Ltd.

BioRestorative Therapies, Inc.

2.70
+0.03001.12%
Post-market: 2.800.1000+3.70%19:39 EDT
Volume:7K
Turnover:19.37K
Market Cap:3.73M
PE:-0.12
High:2.74
Open:2.68
Low:2.66
Close:2.67
52wk High:34.60
52wk Low:2.61
Shares:1.38M
Float Shares:1.25M
Volume Ratio:0.20
T/O Rate:0.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-21.7566
EPS(LYR):-31.6731
ROE:-241.14%
ROA:-118.81%
PB:1.23
PE(LYR):-0.09

Loading ...

Feb 08, 2024

Major Issues Report

Form 8-K - Current report
Feb 05, 2024

Major Issues Report

Form 8-K - Current report
Feb 01, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 16, 2023

Major Issues Report

Form 8-K - Current report
Aug 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 13, 2023

Major Issues Report

Form 8-K - Current report
May 12, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 14, 2023

Major Issues Report

8-K - Current report
Apr 06, 2023

Major Issues Report

8-K - Current report
Mar 28, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 27, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 17, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 17, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Correspondence

CORRESP [Cover] - Correspondence
Feb 07, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 05, 2023

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]